In recent years, the homeobox gene superfamily has been introduced as a master regulator in downstream target genes related to cell development and proliferation. An indispensable role of this family involved in organogenesis development has been widely demonstrated since expression of Six family led to a distinct increase in development of various organs. These functions of Six family genes are primarily based on structure as well as regulatory role in response to external or internal stimuli. In addition to these roles, mutation or aberrant expression of Six family plays a fundamental role in initiation of carcinogenesis, a multistep process including transformation, proliferation, angiogenesis, migration, and metastasis. This suggests that the Six superfamily members can be considered as novel target molecules to inhibit tumor growth and progression. This review focuses on the structure, function, and mechanisms of the Six family in cancer processes and possible strategies to apply these family members for diagnostic, prognostic, and therapeutic purposes.
KawakamiKSatoSOzakiHIkedaKSix family genes—structure and function as transcription factors and their roles in development. BioEssays2000227616–626
2.
KumarJPThe sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci2009664565–583
3.
FujimotoYTanakaSSYamaguchiYLHomeoproteins Six1 and Six4 regulate male sex determination and mouse gonadal development. Dev Cell2013264416–430
4.
WuWRenZLiPSix1: a critical transcription factor in tumorigenesis. Int J Cancer201513661245–1253
5.
WangCAJedlickaPPatrickANSIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest201212251895–1906
6.
BehbakhtKQamarLAldridgeCSSix1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res20076773036–3042
7.
TanJZhangCQianJExpression and significance of Six1 and Ezrin in cervical cancer tissue. Tumour Biol20113261241–1247
8.
YuYKhanJKhannaCHelmanLMeltzerPSMerlinoGExpression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med2004102175–181
9.
SehicDKarlssonJSandstedtBGisselssonDSIX1 protein expression selectively identifies blastemal elements in Wilms tumor. Pediatr Blood Cancer201259162–68
10.
OnoHImotoIKozakiKSIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene201231474923–4934
11.
SchneuwlySKlemenzRGehringWJRedesigning the body plan of Drosophila by ectopic expression of the homoeotic gene Antennapedia. Nature19873256107816–818
12.
Del BeneFWittbrodtJCell cycle control by homeobox genes in development and disease. Semin Cell Dev Biol2005163449–460
13.
GehringWJIkeoKPax 6: mastering eye morphogenesis and eye evolution. Trends Genet1999159371–377
14.
LevineMHoeyTHomeobox proteins as sequence-specific transcription factors. Cell1988554537–540
15.
McGinnisWKrumlaufRHomeobox genes and axial patterning. Cell1992682283–302
16.
IkedaKWatanabeYOhtoHKawakamiKMolecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein. Mol Cell Biol200222196759–6766
17.
OhtoHKamadaSTagoKCooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol199919106815–6824
18.
LiuYNandiSMartelAAntounAIoshikhesIBlaisADiscovery, optimization and validation of an optimal DNA-binding sequence for the Six1 homeodomain transcription factor. Nucleic Acids Res201240178227–8239
19.
LaflammeCFilionCLabelleYFunctional characterization of SIX3 homeodomain mutations in holoprosencephaly: interaction with the nuclear receptor NR4A3/NOR1. Hum Mutat2004246502–508
20.
WinchesterCRobertsonSMacLeodTJohnsonKThomasMExpression of a homeobox gene (SIX5) in borderline ovarian tumours. J Clin Pathol2000533212–217
21.
SoulierJClappierECayuelaJMHOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood20051061274–286
22.
ReichenbergerKJColettaRDSchulteAPVarella-GarciaMFordHLGene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res20056572668–2675
23.
WanFMiaoXQuraishiIKennedyVCreekKEPirisiLGene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer2008123132–40
24.
NgKTManKSunCKClinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer20069581050–1055
25.
LiCMGuoMBorczukAGene expression in Wilms’ tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol200216062181–2190
26.
KalluriRWeinbergRAThe basics of epithelial-mesenchymal transition. J Clin Invest200911961420–1428
27.
TrimboliAJFukinoKde BruinADirect evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res2008683937–945
28.
VergaraDMerlotBLucotJPEpithelial-mesenchymal transition in ovarian cancer. Cancer Lett2010291159–66
29.
BrabletzTHlubekFSpadernaSInvasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs20051791-256–65
OzdamarBBoseRBarrios-RodilesMWangHRZhangYWranaJLRegulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science200530757151603–1609
32.
IkenouchiJMatsudaMFuruseMTsukitaSRegulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci2003116Pt 10 1959–1967
33.
KokkinosMIWafaiRWongMKNewgreenDFThompsonEWWalthamMVimentin and epithelial-mesenchymal transition in human breast cancer—observations in vitro and in vivo. Cells Tissues Organs20071851-3191–203
34.
ZavadilJBöttingerEPTGF-beta and epithelial-to-mesenchymal transitions. Oncogene200524375764–5774
35.
KimKLuZHayEDDirect evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int2002265463–476
36.
HuberMAKrautNBeugHMolecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol2005175548–558
37.
YangJManiSADonaherJLTwist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell20041177927–939
38.
MicalizziDSWangCAFarabaughSMSchiemannWPFordHLHomeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res2010702410371–10380
39.
XuHZhangYAltomareDSix1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes. Carcinogenesis20143561379–1388
40.
McCoyELIwanagaRJedlickaPSix1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest200911992663–2677
41.
GiampieriSManningCHooperSJonesLHillCSSahaiELocalized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol200911111287–1296
42.
BlobeGCSchiemannWPLodishHFRole of transforming growth factor beta in human disease. N Engl J Med2000342181350–1358
43.
AzharMRunyanRBGardCLigand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev Dyn20092382431–442
44.
JakowlewSBTransforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev2006253435–457
45.
SiegelPMMassaguéJCytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer2003311807–821
46.
ChenCRKangYMassaguéJDefective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc Natl Acad Sci USA2001983992–999
47.
ReesJROnwuegbusiBASaveVEAldersonDFitzgeraldRCIn vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res200666199583–9590
48.
MassaguéJTGF-beta signal transduction. Annu Rev Biochem1998671753–791
49.
AtfiADjelloulSChastreEDavisRGespachCEvidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem199727231429–1432
50.
EngelMEMcDonnellMALawBKMosesHLInterdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem19992745237413–37420
51.
FreyRSMulderKMInvolvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res1997574628–633
52.
HartsoughMTMulderKMTransforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem1995270137117–7124
53.
HanafusaHNinomiya-TsujiJMasuyamaNInvolvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem19992743827161–27167
54.
BakinAVTomlinsonAKBhowmickNAMosesHLArteagaCLPhosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem20002754736803–36810
55.
MicalizziDSChristensenKLJedlickaPThe Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J Clin Invest200911992678–2690
56.
CarlsonMEConboyMJHsuMRelative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell200986676–689
57.
MimaeTOkadaMHagiyamaMUpregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin Cancer Res2012184945–955
58.
BrowneGSayanAETulchinskyEZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle201095886–891
59.
BrabletzSBrabletzTThe ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?EMBO Rep2010119670–677
60.
DaveNGuaita-EsteruelasSGutarraSFunctional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem20112861412024–12032
61.
CieplyBFarrisJDenvirJFordHLFrischSMEpithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. Cancer Res201373206299–6309
62.
FordHLKabinguENBumpEAMutterGLPardeeABAbrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci USA1998952112608–12613
63.
PaulesRSLevedakouENWilsonSJDefective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res19955581763–1773
64.
DaveySHanCSRamerSAFission yeast rad12+ regulates cell cycle checkpoint control and is homologous to the Bloom's syndrome disease gene. Mol Cell Biol19981852721–2728
65.
KasaharaHIzumoSIdentification of the in vivo casein kinase II phosphorylation site within the homeodomain of the cardiac tisue-specifying homeobox gene product Csx/Nkx2.5. Mol Cell Biol1999191526–536
66.
CoqueretOBoichotELagenteVSelective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells. Clin Exp Allergy1997277816–823
67.
FienbergAANordstedtCBeltingHGPhylogenetically conserved CK-II phosphorylation site of the murine homeodomain protein Hoxb-6. J Exp Zool1999285176–84
68.
BourbonHMMartin-BlancoERosenDKornbergTBPhosphorylation of the Drosophila engrailed protein at a site outside its homeodomain enhances DNA binding. J Biol Chem19952701911130–11139
69.
FordHLLandesman-BollagEDacwagCSStukenbergPTPardeeABSeldinDCCell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem20002752922245–22254
RiveraAMavilaABaylessKJDavisGEMaxwellSACyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells. Cell Mol Life Sci200663121425–1439
74.
Müller-TidowCDiederichsSSchraderMGCyclin A1 is highly expressed in aggressive testicular germ cell tumors. Cancer Lett2003190189–95
75.
YamCHFungTKPoonRYCyclin A in cell cycle control and cancer. Cell Mol Life Sci20025981317–1326
76.
WegielBBjartellAEkbergJGadaleanuVBrunhoffCPerssonJLA role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer. Oncogene200524426385–6393
77.
KhannaCWanXBoseSThe membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med2004102182–186
78.
Xu-DongSZanSShui-erZExpression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma. Clin Invest Med2009322E180–E188
79.
Jansen-DürrPMeichleASteinerPDifferential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA19939083685–3689
80.
IwanagaRWangCAMicalizziDSExpression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Res2012144R100
81.
LiZTianTLvFSix1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS ONE201383e59203
82.
TabasinezhadMSamadiNGhanbariPSphingosin 1-phosphate contributes in tumor progression. J Cancer Res Ther201394556–563
83.
ChristensenKLBrennanJDAldridgeCSFordHLCell cycle regulation of the human Six1 homeoprotein is mediated by APC(Cdh1). Oncogene200726233406–3414
84.
MenkeCGoncharovTQamarLTRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitro. PLoS ONE201161e14527
85.
NyåkernMCappelliniAMantovaniIMartelliAMSynergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol Cancer Ther2006561559–1570
86.
ZhangLWangXChenPMiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer2013131290
87.
XiaYZhuYMaTmiR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC. FEBS Lett2014588203703–3712
88.
ZhaoHXuZQinHGaoZGaoLmiR-30b regulates migration and invasion of human colorectal cancer via SIX1. Biochem J20144601117–125
89.
ZhaoZTZhouWLiuLYLanTZhanQMSongYM(Molecular mechanism and effect of microRNA185 on proliferation, migration and invasion of esophageal squamous cell carcinoma). Zhonghua Yi Xue Za Zhi201393181426–1431
90.
SmithALIwanagaRDrasinDJThe miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene201231505162–5171
91.
LiZTianTHuXSix1 mediates resistance to paclitaxel in breast cancer cells. Biochem Biophys Res Commun20134413538–543
92.
GallettiEMagnaniMRenzulliMLBottaMPaclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes. ChemMedChem200727920–942
